F2 Ventures

Portfolio · 3

Clutch Security

Securing the Invisible Ecosystem of Non-Human Identities

1 round $8.5M committed Latest: 2024-07

Breeze Security

Unified Security Platform

Led ★ 1 round $7.0M committed Latest: 2023-01

Chiasma

Oral Therapeutic Options for Patients with Rare Diseases

3 rounds $121.7M committed Latest: 2015-02

Investment activity

1 portfolio exit on record.

Q&A

What is F2 Ventures' most recent investment?

F2 Ventures most recently invested in Clutch Security, a B2B company focused on securing non-human identities, in a Series A round in July 2024. This round raised $28.5M.

What is F2 Ventures' second most recent investment?

F2 Ventures invested in Breeze Security, a B2B unified security platform, in a Seed round in January 2023. This round raised $7M.

What sectors does F2 Ventures primarily invest in?

F2 Ventures shows a concentration in Cyber Security and Health Tech & Life Sciences, with two portfolio companies in Cyber Security and one in Health Tech & Life Sciences.

Has F2 Ventures had any notable exits?

Yes, F2 Ventures had an exit with Chiasma, an oral therapeutic company, which went public on NASDAQ in July 2015 with a valuation of $562M.

What is the typical funding stage for F2 Ventures' investments?

F2 Ventures has invested across various stages, including Seed and Series A rounds for its recent portfolio companies, Breeze Security and Clutch Security.

What is the total amount raised by F2 Ventures' portfolio company, Clutch Security?

Clutch Security, a portfolio company of F2 Ventures, has raised $28.5M in its Series A funding round.

What is the total amount raised by F2 Ventures' portfolio company, Breeze Security?

Breeze Security, a portfolio company of F2 Ventures, has raised $7M in its Seed funding round.